75 related articles for article (PubMed ID: 206866)
1. [Calcitonin sensitivity testing in patients with kidney diseases. Changes in serum calcium, phosphorus and plasma cyclic adenosine monophosphate levels under the effect of calcitonin in healthy subjects and uremic patients under chronic hemodialysis].
Szücs J; Steczek K
Orv Hetil; 1978 May; 119(20):1220-4. PubMed ID: 206866
[No Abstract] [Full Text] [Related]
2. Effect of calcitonin on plasma cAMP in uraemic man.
Szücs J; Horváth T
Horm Metab Res; 1980 Jan; 12(1):44-5. PubMed ID: 6244220
[No Abstract] [Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Influence of calcium infusion on calcitonin and parathyroid hormone concentrations in normal and hemodialyzed subjects.
Isaac R; Nivez MP; Piamba G; Fillastre JP; Ardaillou R
Clin Nephrol; 1975 Jan; 3(1):14-7. PubMed ID: 1126058
[TBL] [Abstract][Full Text] [Related]
5. Studies of the elevated extracellular concentration of cyclic AMP in uremic man.
Hamet P; Stouder DA; Ginn HE; Hardman JG; Liddle GW
J Clin Invest; 1975 Aug; 56(2):339-45. PubMed ID: 168232
[TBL] [Abstract][Full Text] [Related]
6. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
Chudek J; Piecha G; Kokot F; Wiecek A
J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
[TBL] [Abstract][Full Text] [Related]
7. Effect of salmon calcitonin on renal excretion of adenosine 3', 5' monophosphate in man.
Ardaillou R; Isaac R; Nivez MP; Kuhn JM; Cazor JL; Fillastre JP
Horm Metab Res; 1976 Mar; 8(2):136-40. PubMed ID: 177347
[TBL] [Abstract][Full Text] [Related]
8. [Values of active metabolites of vitamin D in the serum of uremic patients on long-term hemodialysis].
Stefanović V; Kostić S; Dordević V; Grubor-Lajsić G; Mitić-Zlatković M
Acta Med Iugosl; 1988; 42(2):81-8. PubMed ID: 3389195
[No Abstract] [Full Text] [Related]
9. Plasma calcitonin concentration in patients treated with chronic dialysis: differences between hemodialysis and CAPD.
Martínez ME; Miguel JL; Gómez P; Selgas R; Salinas M; Gentil M; Mateos F; Montero JL; Sánchez Sicilia L
Clin Nephrol; 1983 May; 19(5):250-3. PubMed ID: 6851265
[TBL] [Abstract][Full Text] [Related]
10. Plasma calcium fraction dynamics in uremic patients undergoing hemodialysis.
Asad SN; Olmer AJ; Letteri JM
Miner Electrolyte Metab; 1984; 10(5):333-6. PubMed ID: 6493162
[TBL] [Abstract][Full Text] [Related]
11. [Effect of parathyroid hormone and calcitonin on serum levels of adenosine-3'5'-monóphosphate and electrolytes in patients treated with repeated hemodialysis].
Czekalski S; Eder M; Gryczyńska M
Pol Arch Med Wewn; 1975 Aug; 54(2):119-26. PubMed ID: 169512
[No Abstract] [Full Text] [Related]
12. Plasma immunoreactive N-terminal parathyroid hormone and cyclic AMP and cyclic GMP urinary levels in man after I. M. administration of two different doses of porcine calcitonin.
Vigo PL; Milhaud G; Peracchi M; Girardello R; Ortolani S; Polli EE
Biomedicine; 1980 Dec; 33(8):255-9. PubMed ID: 6260260
[TBL] [Abstract][Full Text] [Related]
13. Cimetidine and circulating calciotropic hormone levels in uremic patients: evidence for a suppressive effect on calcitonin secretion.
Sebert JL; Decourcelles PH; Morinière P; Calmette C; Gueris J; Makdassi R; Khassouf J; Andrejak M; Fournier A
Miner Electrolyte Metab; 1982 Dec; 8(6):293-9. PubMed ID: 7167135
[TBL] [Abstract][Full Text] [Related]
14. [Effect of aluminum hydroxide on serum calcium, serum phosphorus and calcium turnover in uremic patients].
Friis T; Weeke E
Nord Med; 1969 Sep; 82(37):1136-42. PubMed ID: 5354523
[No Abstract] [Full Text] [Related]
15. Evaluation of the biological activity of unmodified synthetic eel calcitonin rectal capsules. Comparison with intramuscular administration and placebo.
Fiore CE; Fiorito S; Foti R; Motta M; Incognito C; Grasso G
Int J Clin Pharmacol Res; 1992; 12(4):185-9. PubMed ID: 1338433
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin secretion in chronic renal patients treated with hemodialysis.
Gozariu L; Manasia M; Paţiu IM; Vlăduţiu D; Barabas E; Spânu C; Căprioară M
Endocrinologie; 1981; 19(4):253-6. PubMed ID: 7323650
[TBL] [Abstract][Full Text] [Related]
17. Red blood cell calcium homeostasis in patients with end-stage renal disease.
Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
[TBL] [Abstract][Full Text] [Related]
18. Plasma adenosine 3':5'--cyclic monophosphate response to glucagon in uremia.
Vlachoyannis J; Schoeppe W
Klin Wochenschr; 1982 Jul; 60(13):651-7. PubMed ID: 6289001
[TBL] [Abstract][Full Text] [Related]
19. Metabolic effects of rectal administration of unmodified eel calcitonin in humans.
Nuti R; Martini G; Frediani B; Giovani S; Valenti R; Marcocci A; Ciappi A
Drugs Exp Clin Res; 1992; 18(9):395-400. PubMed ID: 1338592
[TBL] [Abstract][Full Text] [Related]
20. [The calcium-phosphorus balance and parathormone behavior in 7 patients treated with integral hemofiltration].
Civati G; Guastoni C; Perego A; Galato R; Brando B; Grillo C; Surian M; Colussi G; Teatini U; Minetti L
Minerva Nefrol; 1981; 28(2):171-4. PubMed ID: 7290521
[No Abstract] [Full Text] [Related]
[Next] [New Search]
